Concurrent changes in 1H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: Possible implications for schizophrenia

Neurochemistry International

Volumn 69, Issue 1, 2014, Pages 20-27

  Xuan, Yinghua ^a,b   Yan, Gen ^b   Peng, Hui ^b   Wu, Renhua ^b   Xu, Haiyun ^a,b  

^a SHANDONG MENTAL HEALTH CENTER   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Brain metabolites; Cuprizone; Mouse; MRS; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; ANTIOXIDANT; ASPARTIC ACID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CREATINE; CREATINE PHOSPHATE; CUPRIZONE; DRUG METABOLITE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLYCEROPHOSPHORYLCHOLINE; HYDROGEN PEROXIDE; INOSITOL; LACTIC ACID; MALONALDEHYDE; N ACETYLASPARTYLGLUTAMIC ACID; PHOSPHORYLCHOLINE; SCYLLONOSITOL; SUPEROXIDE DISMUTASE; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; CHELATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN; BRAIN NERVE CELL; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPLORATORY BEHAVIOR; FRONTAL CORTEX; HIPPOCAMPUS; LIPID PEROXIDATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; SCHIZOPHRENIA; SOCIAL INTERACTION; SOCIAL STATUS; SPATIAL MEMORY; WORKING MEMORY; ANIMAL; C57BL MOUSE; DEMYELINATING DISEASE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; OLIGODENDROGLIA; PATHOPHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; BRAIN; CHELATING AGENTS; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; HYDROGEN PEROXIDE; MALE; MICE, INBRED C57BL; OLIGODENDROGLIA; SCHIZOPHRENIA;

EID: 84896954435     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.02.004     Document Type: Article

References (57)

1. P. Acs, and B. Kalman Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model Autoimmunity: Methods and Protocols, Methods in Molecular Biology 2012 Spinger Science + Business Media New York pp. 403-431
2. C. Aston, L. Jiang, and B.P. Sokolov Microarray analysis of postmortem temporal cortex from patients with schizophrenia J. Neurosci. Res. 77 2004 858 866
3. K. Bénardais, A. Kotsiari, J. Škuljec, P.N. Koutsoudaki, V. Gudi, V. Singh, F. Vulinović, T. Skripuletz, and M. Stangel Cuprizone [bis (cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes Neurotox. Res. 24 2013 1 7
4. O. Berton, C.A. McClung, R.J. DiLeone, V. Krishnan, W. Renthal, S.J. Russo, D. Graham, N.M. Tsankova, C.A. Bolanos, and M. Rios Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress Science 311 2006 864 868
5. A. Bitsch, H. Bruhn, V. Vougioukas, A. Stringaris, H. Lassmann, J. Frahm, and W. Brück Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy Am. J. Neuroradiol. 20 1999 1619 1627
6. A.A. Capizzano, J.L. Nicoll Toscano, and B.C. Ho Magnetic resonance spectroscopy of limbic structures displays metabolite differences in young unaffected relatives of schizophrenia probands Schizophr. Res. 131 2011 4 10
7. P. Chandran, J. Upadhyay, S. Markosyan, A. Lisowski, W. Buck, C.L. Chin, G. Fox, F. Luo, and M. Day Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice Neuroscience 202 2012 446 453
8. K.L. Davis, D.G. Stewart, J.I. Friedman, M. Buchsbaum, P.D. Harvey, P.R. Hof, J. Buxbaum, and V. Haroutunian White matter changes in schizophrenia: evidence for myelin-related dysfunction Arch. Gen. Psychiat. 60 2003 443 456
9. G. Douaud, C. Mackay, J. Andersson, S. James, D. Quested, M.K. Ray, J. Connell, N. Roberts, T.J. Crow, P.M. Matthews, S. Smith, and A. James Schizophrenia delays and alters maturation of the brain in adolescence Brain 132 2009 2437 2448
10. G. Douaud, S. Smith, M. Jenkinson, T. Behrens, H. Johansen-Berg, J. Vickers, S. James, N. Voets, K. Watkins, P.M. Matthews, and A. James Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia Brain 130 2007 2375 2386
11. R. Edwards, and V.B. Mosher Alcohol abuse, anaesthesia, and intensive care Anaesthesia 35 1980 474 489
12. S.K. Fisher, J.E. Novak, and B.W. Agranoff Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance J. Neurochem. 82 2002 736 754
13. N. Franco-Pons, M. Torrente, M.T. Colomina, and E. Vilella Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination Toxicol. Lett. 169 2007 205 213
14. B. Gangadhar, P. Jayakumar, D. Subbakrishna, N. Janakiramaiah, and M. Keshavan Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study Am. J. Psychiatry 161 2004 1304 1306
15. F.B. Goldstein Biosynthesis of N-acetyl-l-aspartic acid Biochim. Biophys. Acta 33 1959 583 584
16. J.R. Gregg, N.R. Herring, A.V. Naydenov, R.P. Hanlin, and C. Konradi Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats Schizophr. Res. 113 2009 277 287
17. Y. Hakak, J.R. Walker, C. Li, W.H. Wong, K.L. Davis, J.D. Buxbaum, V. Haroutunian, and A.A. Fienberg Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia Proc. Natl. Acad. Sci. USA 98 2001 4746 4751
18. D. Häussinger, J. Laubenberger, S. vom Dahl, T. Ernst, S. Bayer, M. Langer, W. Gerok, and J. Hennig Proton magnetic resonance spectroscopy studies on human brain/wyanositol in hypo-osmolarity and hepatic encephalopathy Gastroenterology 107 1994 1475 1480
19. 31P-MRS study of basal ganglia Psychiatry Res. 181 2010 237 240
20. F. Jessen, N. Fingerhut, A.M. Sprinkart, K.U. Kühn, N. Petrovsky, W. Maier, H.H. Schild, W. Block, M. Wagner, and F. Träber N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia Schizophr. Bull. 39 2013 197 205
21. P. Katsel, K.L. Davis, and V. Haroutunian Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study Schizophr. Res. 79 2005 157 173
22. 1H spectroscopy study Schizophr. Res. 115 2009 88 93
23. M. Kipp, T. Clarner, J. Dang, S. Copray, and C. Beyer The cuprizone animal model: new insights into an old story Acta Neuropathol. 118 2009 723 736
24. D.-W. Lee, S.-Y. Kim, J.-H. Kim, T. Lee, C. Yoo, Y.-K. Nam, J.-Y. Jung, H.-C. Shin, H.-Y. Kim, and D.-J. Kim Quantitative assessment of neurochemical changes in a rat model of long-term alcohol consumption as detected by in vivo and ex vivo proton nuclear magnetic resonance spectroscopy Neurochem. Int. 62 2013 502 509
25. Li, Y., Zhang, Y., Han, W., Hu, F., Qian, Ye, Chen, Q., 2013. TRO19622 promotes myelin repair in a rat model of demyelination. Int. J. Neurosci. http://dx.doi.org/10.3109/00207454.2013.804523.
26. D. Liebetanz, and D. Merkler Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis Exp. Neurol. 202 2006 217 224
27. R.J. Maddock, and M.H. Buonocore MR spectroscopic studies of the brain in psychiatric disorders Curr. Top. Behav. Neurosci. 11 2012 199 251
28. M. Makinodan, T. Yamauchi, K. Tatsumi, H. Okuda, T. Takeda, K. Kiuchi, M. Sadamatsu, A. Wanaka, and T. Kishimoto Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 978 985
29. G.K. Matsushima, and P. Morell The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system Brain Pathol. 11 2001 107 116
30. J.R. Moffett, B. Ross, P. Arun, C.N. Madhavarao, and A. Namboodiri N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology Prog. Neurobiol. 81 2007 89 131
31. P. Morell, C. Barrett, J. Mason, A. Toews, J. Hostettler, G. Knapp, and G. Matsushima Gene expression in brain during cuprizone-induced demyelination and remyelination Mol. Cell. Neurosci. 12 1998 220 227
32. Napolitano, A., Shah, K., Schubert, M.I., Porkess, V., Fone, K.C., Auer, D.P., 2013. In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced nmda antagonism: a rodent study at 7.0 t. Schizophr. Bull. (Epub ahead of print).
33. P. Ohrmann, A. Siegmund, T. Suslow, A. Pedersen, K. Spitzberg, A. Kersting, M. Rothermundt, V. Arolt, W. Heindel, and B. Pfleiderer Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study J. Psychiatr. Res. 41 2007 625 634
34. D. Öngür, A.P. Prescot, J.E. Jensen, B.M. Cohen, and P.F. Renshaw Creatine abnormalities in schizophrenia and bipolar disorder Psychiatry Res. 172 2009 44 48
35. J.W. Pan, and K. Takahashi Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain Ann. Neurol. 57 2005 92 97
36. R.E. Peterson, and M.E. Bollier Spectrophotometric determination of serum copper with biscyclohexanoneoxalyldihydrazone Anal. Chem. 27 1955 1195 1197
37. 1H spectra with LC Model NMR Biomed. 14 2001 260 264
38. S.A. Schobel, N.H. Chaudhury, U.A. Khan, B. Paniagua, M.A. Styner, I. Asllani, B.P. Inbar, C.M. Corcoran, J.A. Lieberman, and H. Moore Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver Neuron 78 2013 81 93
39. 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest Eur. J. Neurosci. 20 2004 749 756
40. 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis Neuropsychopharmacology 30 2005 1949 1962
41. R.G. Steen, C. Mull, R. Mcclure, R.M. Hamer, and J.A. Lieberman Brain volume in first-episode schizophrenia Systematic review and meta-analysis of magnetic resonance imaging studies Br. J. Psychiatry 188 2006 510 518
42. N. Tandon, N.R. Bolo, K. Sanghavi, I.T. Mathew, A.N. Francis, J.A. Stanley, and M.S. Keshavan Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy Schizophr. Res. 2013 2013 10.1016/j.schres. 05.024
43. S.Y. Tayoshi, M. Nakataki, S. Sumitani, K. Taniguchi, S. Shibuya-Tayoshi, S. Numata, J.-I. Iga, S.-I. Ueno, M. Harada, and T. Ohmori GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study Schizophr. Res. 117 2010 83 91
44. ∅. Torkildsen, L. Brunborg, K.M. Myhr, and L. Bø The cuprizone model for demyelination Acta Neurol. Scand. 117 2008 72 76
45. G. Venturini Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo J. Neurochem. 21 1973 1147 1151
46. H. Wang, C. Li, H. Wang, F. Mei, Z. Liu, H.-Y. Shen, and L. Xiao Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit Neurosci. Bull. 29 2013 251 259
47. L. Xiao, H. Xu, Y. Zhang, Z. Wei, J. He, W. Jiang, X. Li, L. Dyck, R. Devon, and Y. Deng Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes Mol. Psychiatry 13 2007 697 708
48. Xu, H., Yang, H.-J., Li, X., 2013. Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone. Eur. Arch. Psychiatry Clin. Neurosci. (e-pub ahead of print 1 June 2013, 1-9).
49. H. Xu, H.-J. Yang, G.M. Rose, and X. Li Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs Front. Behav. Neurosci. 5 2011 2011 10.3389/fnbeh.00031
50. H. Xu, H.-J. Yang, Y. Zhang, R. Clough, R. Browning, and X.-M. Li Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone Behav. Neurosci. 123 2009 418 429
51. H. Xu, H. Yang, B. McConomy, R.A. Browning, and X. Li Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics Front. Behav. Neurosci. 4 2010 2010 10.3389/fnbeh.00008
52. D. Yang, Z. Xie, D. Stephenson, D. Morton, C.D. Hicks, T.M. Brown, R. Sriram, S. O'Neill, D. Raunig, and T. Bocan Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510) NeuroImage 54 2011 2652 2658
53. S.Y. Yoo, S. Yeon, C.-H. Choi, D.-H. Kang, J.-M. Lee, N.Y. Shin, W.H. Jung, J.-S. Choi, D.-P. Jang, and J.S. Kwon Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus Schizophr. Res. 111 2009 86 93
54. J.H. Yoon, R.J. Maddock, A. Rokem, M.A. Silver, M.J. Minzenberg, J.D. Ragland, and C.S. Carter GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression J. Neurosci. 30 2010 3777 3781
55. H. Zhang, Y. Zhang, H. Xu, L. Wang, J. Zhao, J. Wang, Z. Zhang, Q. Tan, J. Kong, Q. Huang, and X. Li Locomotor activity and anxiety status, but not spatial working memory, are affected in mice after brief exposure to cuprizone Neurosci. Bull. 29 2013 633 641
56. Y. Zhang, H. Xu, W. Jiang, L. Xiao, B. Yan, J. He, Y. Wang, X. Bi, X. Li, and J. Kong Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse Schizophr. Res. 106 2008 182 191
57. Y. Zhang, H. Zhang, L. Wang, W. Jiang, H. Xu, L. Xiao, X. Bi, J. Wang, S. Zhu, and R. Zhang Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination Schizophr. Res. 138 2012 8 17